论文部分内容阅读
目的分析胸腔镜下肺癌根治术在非小细胞肺癌(NSCLC)患者中的应用效果。方法选取2008年1月—2011年1月在恩施州中心医院行胸腔镜下肺癌根治术的NSCLC患者415例,其中T1期201例、T2期132例、T3期82例,比较不同分期患者手术时间、淋巴结清扫个数、术后并发症发生率、5年生存率。结果所有患者顺利完成胸腔镜下肺癌根治术。不同分期患者手术时间比较,差异无统计学意义(P>0.05)。不同分期患者淋巴结清扫个数比较,差异有统计学意义(P<0.05)。T1期、T2期、T3期患者术后并发症发生率分别为4.0%、4.5%、3.7%,差异无统计学意义(P>0.05)。T1期、T2期、T3期患者5年生存率分别为72.6%、41.7%、25.6%,差异有统计学意义(P>0.05)。结论胸腔镜下肺癌根治术在NSCLC患者中的应用效果良好,适用于不同分期NSCLC患者。
Objective To analyze the effect of thoracoscopic lung cancer radical mastectomy in patients with non-small cell lung cancer (NSCLC). Methods A total of 415 NSCLC patients undergoing thoracoscopic lung cancer radical surgery at Enshi Central Hospital from January 2008 to January 2011 were selected. Among them, 201 cases were T1, 132 cases were T2 and 82 cases were T3. Time, the number of lymph node dissection, the incidence of postoperative complications, 5-year survival rate. Results All patients successfully completed thoracoscopic lung cancer radical surgery. There was no significant difference in operation time between different stages (P> 0.05). The number of lymph node dissection in patients with different stages was significantly different (P <0.05). The incidence of postoperative complications in stage T1, T2 and T3 were 4.0%, 4.5% and 3.7%, respectively, with no significant difference (P> 0.05). The 5-year survival rates of T1, T2 and T3 patients were 72.6%, 41.7% and 25.6%, respectively, with significant difference (P> 0.05). Conclusions Thoracoscopic lung cancer radical resection is effective in patients with NSCLC and is suitable for patients with different stages of NSCLC.